Northwest Biotherapeutics Inc (NASDAQ:NWBO)

Data as of Apr 17
 +0.18 / +3.16%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Northwest Biotherapeutics, Inc. is engaged in the development and discovery of innovative immunotherapies for cancer. Its products includes Dendritic Cell Immunotherapy, Therapeutic Monoclonal Antibodies, and Imaging Metastatic Prostate Cancer. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.

Contact Information

Northwest Biotherapeutics, Inc.
4800 Montgomery Lane
Bethesda Maryland 20814
P:(240) 497-9024
Investor Relations:
(202) 841-7909



Mutual fund holders8.30%
Other institutional5.98%
Individual stakeholders12.13%

Top Executives

Linda F. PowersChairman, President & Chief Executive Officer
Anthony E. MaidaChief Operating Officer
Alton L. BoyntonChief Scientific Officer & Director
Marnix L. BoschChief Technology Officer
Leslie J. GoldmanSVP-Business Development & Head-Media Relations

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.